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Introduction
Upon binding to its ligand, the epidermal growth factor (EGF) receptor dimerizes, phosphorylates itself and other intracellular proteins, and initiates an array of signaling events that are critical for cell growth and survival. The activation of the EGF receptor (EGFR) by ligand also causes its own internalization; internalized EGFRs are sorted to endosomes and lysosomes, where they are inactivated by proteolytic degradation. ,2 Although generally acknowledged as a plasma membrane protein, EGFR has also been found in caveolae, the Golgi complex, endoplasmic reticulum, lysosome-like structures, the nuclear envelope and the nucleus. 3, 4 Recently, a mitochondrial location of EGFR was also reported. 5 Boerner and co-workers have found that EGFR can translocate to the mitochondria through interaction with the subunit II of cytochrome c oxidase (Cox) independent of ligand binding. Nevertheless, the mechanism of EGFR mitochondrial translocation remains unclear.
In addition to EGF, varieties of non-ligands were shown to induce EGFR phosphorylation and transactivation. 6, 7 In A43 cells, EGFR autophosphorylation can be upregulated upon exposure to rapamycin, 8 a fungicide produced by Streptomyces hygroscopicus. Rapamycin can form an inhibitory complex with the immunophilin FKBP2 and then specifically inhibit the mammalian Target of Rapamycin (mTOR) with high efficiency. 9 Like the yeast counterpart, mTOR functions as a serine/threonine protein kinase and belongs to the phosphoinositide kinase-related kinase (PIKK) family. 0 Among mTOR's targets, ribosomal S6 kinase (S6K) is extensively studied and known to regulate a variety of cellular activities. Moreover, mTOR signaling has been found to play a vital role in the relaying of autophagic stimuli. 0, Autophagy (self-eating) is an intracellular process involving the bulk degradation of cytoplasmic components by autophagolysosomes. 2, 3 Accumulated evidence has revealed that autophagy plays a selective role in organelle degradation and turnover, 2, [4] [5] [6] and participates in programmed cell death. 7, 8 While rapamycin is widely used as an autophagy inducer, 9,9 3-MA is used as an inhibitor. 20 The identification of various autophagy genes in yeast and human homologues of these genes has extended our knowledge of the molecular machinery required for this intracellular degradation process. Besides regulating cell proliferation both in vivo and in vitro, EGF can also activate the apoptotic program in cells expressing high quantities of EGFRs 2, 22 and induce the autophagic process in A43 cells. 23 Noticeably, mitochondria also play a crucial role in programmed cell death and autophagic processes. Therefore, we were intrigued to investigate the potential ties between EGFR and mitochondria. In our present study, we reveal that rapamycin induces autophagy and increases EGFR mitochondrial translocation in A43 cells, whereas the inhibition of autophagy by 3-MA greatly decreases the amount of mitochondrial EGFR. On the other hand, knockdown of the Beclin protein, which is essential for autophagy, remarkably reduces the migration of EGFR onto mitochondria induced by rapamycin. Moreover, the incubation of the cells with etoposide, which is known to stimulate apoptosis, decreases the content of mitochondrial EGFR. EGF treatment or EGFR knockdown by siRNA results in a greater decrease of cell viability in those cells possessing more mitochondrial EGFRs. From the above observations, we believe that an adequate quantity of mitochondrial EGFR is critical for cell survival in certain cell types.
Results

EGFR is localized on mitochondria.
To prove the mitochondrial localization of EGFR, we performed both immunoelectron microscopy and immunofluorescence on A43 cells. As shown in Figure A , with EGFR antibody, gold particles are seen inside (filled arrowheads) as well as on the periphery (open arrowheads) of mitochondria (Fig. A, right) , and no staining of colloidal gold was found in the control sample without primary antibody (Fig. A, left) , indicating the presence of mitochondrial EGFR. In immunofluorescence staining, co-localization of EGFR-Cy3 and YFP-Cox7a2 (Fig. B, upper ) in A43 cells was observed, whereas there was no staining in the negative control without primary antibody (Suppl. Fig. A) . The co-localization was enhanced under certain culture conditions (i.e., in the presence of rapamycin) (Fig. B, middle) . Similar results of enhanced co-localization between GFP-EGFR and MtHsp70-Cy3 were also obtained in PAE, which stably expressed GFP-EGFR (Fig. B, bottom) . The microscopy findings prompted us to carry out biochemical fractionation and immuneoblotting with organelle-specific antibodies, including anti-EEA (early endosome), p70S6K (cytosolic) and anti-MtHsp70 (mitochondria). Consistent with a previous report, 5 abundant EGFRs were found in the mitochondrial fraction of A43 cells (Fig. C) . Isolation of mitochondria, mitochondrial enrichment and cytosol were confirmed by immunoblotting with antibody against MtHsp70, a protein specifically located on mitochondria but not detected in the cytosolic fraction. In the meantime, the mitochondrial fraction was found to be free of EEA, suggesting that isolated mitochondria were not contaminated with the endosomal compartment (Fig. C) .
Mitochondrial EGFR was both PK-sensitive and PK-resistant. To determine if EGFR is located on the inner or outer membrane of mitochondria, the tolerance of the mitochondrially-associated EGFR to PK was examined. A43 cells were transiently transfected with Bcl-x L -YFP (without splitting the cells after transfection), and mitochondria were then extracted. Upon PK exposure, Bcl-x L (a and GFP-EGFR expressing PAE (bottom) in the absence (upper) or presence (middle and bottom) of rapamycin (0.1 μM, 24 h) were permeabilized and immunostained with anti-EGFR (A431) or anti-MtHsp70-Cy3 (PAE) respectively, followed with Cy3-labeled secondary antibodies for imaging. The yellow color representes the overlay between red and green fluorescence. (C) Subcellular fractionation of homogenized A431 cells and the resulting fractions were immunoblotted with the antibodies indicated. TH: total homogenate; N-pellet: nuclear pellet; V-pellet: vesicular pellet; Cyto/S100: cytosol/ S100; Hmmbp: heavy membrane pellet; P-Mito: purified mitochondria. protein associated with the outer membrane of mitochondria) and EGFR were almost completely degraded, whereas CoxIV-IV (an inner mitochondrial membrane protein) exhibited complete resistance to PK treatment ( Fig. 2A) . In later experiments, we found that mitochondrial EGFRs from A43 ( Fig. 7A ), PAE-EGFR (Fig. 2C ) and HeLa cells (Suppl. Fig. B) were also resistant to PK treatment in a cell-and mutated receptor type-dependent manner. Interestingly, in PAE cells, EGFR with the kinase domain mutated and four critical tyrosine residues substituted (EGFR-5M) was demonstrated to be PK-sensitive. In contrast, the EGFR mutant (C'022) lacking 64 amino acids from the C terminus, displayed PK resistance ( Fig. 2B and C). Together with findings from IEM, the results indicate that the receptor can associate with both the outer and inner membrane of mitochondria. Autophagy promotes EGFR mitochondrial translocation. To investigate the probable connection between autophagy and EGFR mitochondrial translocation, we employed rapamycin, which can activate autophagy even under nutrient-rich conditions. Upon application of the reagent to A43 cells, GFP-LC3, which is widely used to monitor autophagy, 28 became concentrated, and the amount of punctate GFP-LC3 fluorescence increased significantly in a time-dependent manner (p < 0.05) (Fig. 3A) , whereas GFP-LC3 remained diffuse in the cytoplasm of the control cells. Since the ratio of LC3-II to actin is considered a more accurate indicator for determining autophagy, 29 immunoblotting was carried out to verify the morphological findings by detecting the protein expression of LC3. Compared with the control, cells grown in medium with rapamycin had an increased ratio of LC3-II/actin (Fig. 3B) . These findings indicated that A43 cells indeed underwent an autophagic process following the rapamycin challenge. Meanwhile, rapamycin treatment markedly increased the amount of mitochondrial EGFR at two different concentrations ( Fig. 3C ) and decreased the phosphorylation of p70S6 kinase (p70S6K) when compared to the control conditions (Fig. 3E) . Noticeably, two concentrations of rapamycin exhibited a similar ability to enhance EGFR mitochondrial translocation. Given that p70S6K is a readout and downstream effector of mTOR, these data reaffirmed our observation of rapamycin-induced autophagy in the cells. It should be noted that incubation of rapamycin (24 hours) had no obvious effect on cell viability in the present study (Fig. 3D) .
Serum starvation can activate cellular autophagy. Thus, we next examined the GFP-EGFR location in PAE cells during serum deprivation. Upon prolonged starvation, co-localization between EGFRs and MitoTracker Red was enhanced in the perinuclear region (Fig. 4A) . In A43 cells, serum deprivation stimulated a significant accumulation of punctate GFP-LC3 (p < 0.0) and led to an increased mitochondrial translocation of the receptor ( Fig.  4B and C). Meanwhile, serum starvation for 24 hours resulted in no obvious apoptosis as determined by flow cytometry analysis and DAPI staining (Suppl. Fig. 2A and C).
The inhibition of autophagy leads to a decreased mitochondrial EGFR. To provide further evidence that autophagy is involved in the mitochondrial translocation of EGFR, 3-MA was introduced to A43 cells. Together with leupeptin, 3-MA was found to suppress mitochondrial transfer of EGFR, and led to a decrease of cell viability (p < 0.0) (Fig. 5A ). As expected, the combination of 3-MA and leupeptin displayed a larger inhibitory effect on EGFR transfer onto mitochondria than 3-MA alone ( Fig. 5A and Suppl. Fig. C) . Concurrently, the inhibitor decreased the ratio of LC3-II to actin as well (Suppl. Fig. C ). In addition, 3-MA was shown to block the mitochondrial translocation of EGFR induced by EGF (Fig. 5B) . Findings with pharmacological inhibitors prompted us to further explore the relationship between autophagy and mitochondrial location of EGFR via depletion of the endogenous autophagic proteins. Using the siRNA approach, we successfully reduced the intracellular amount of the Beclin protein, which is essential for autophagy (Fig. 5C ). 30 Interestingly, the reduction of Beclin protein resulted in no reduction of basal mitochondrial EGFR, yet, greatly decreased EGFR mitochondrial migration induced by rapamycin (Fig. 5D) .
Programmed cell death reduces the mitochondrial localization of EGFR. Given that 3-MA reduced the cell viability (Fig. 5A ), we proposed that EGFR localization in mitochondria may also be mediated by programmed cell death. To prove this hypothesis, we analyzed EGFR mitochondrial migration following exposure to etoposide, a topoisomerase II inhibitor and an apoptotic inducer. Upon application of etoposide to A43 cells, we found that cell viability significantly correlated with the amount of mitochondrial EGFR (p < 0.00) (Fig. 6A) . Cell death was confirmed by flow cytometry analysis and DAPI staining, both of which revealed that the cells underwent apoptosis with incubation of etoposide (Suppl. Fig. 2B and C) . Moreover, when the decline of cell viability by etoposide was blocked by z-VAD-FMK, the pan-caspase inhibitor, we noted no attenuation in mitochondrial EGFR expression (Fig. 6A ) and, concurrently, no marked change in cell viability (Fig. 6B) . In contrast to the aftereffects of rapamycin exposure and serum-deprivation, respectively, GFP-LC3 staining remained diffuse (rather than punctate) when challenged with either etoposide or 3-MA (Suppl. Fig. 2D ). Moreover, 3-MA significantly inhibited the formation of punctate GFP-LC3 by rapamycin (p < 0.0) and decreased the ratio of LC3-II to actin as well (Suppl. Fig. 2D-F ). All these observations indicate that the localization of mitochondrial EGFR is subjected to mediation by both autophagy and apoptotic cell death. Mitochondrial EGFR is correlated with the lost of cell viability induced by EGF challenge and EGFR depletion. Provided that EGFR is indeed on mitochondria, we next examined the effects of EGF on this subset of the receptor. A previous study showed that EGF exposure leads to upregulation of EGFR in mitochondria. 5 Here, we revealed that EGF could increase or decrease the amount of mitochondrial EGFR in a variety of cells tested (Figs. 5B and 7A and Suppl. Fig. B) , and that its induced mitochondrial migration of EGFR is time-dependent and can be blocked with 3-MA in A43 cells (Figs. 5B and 7A ). To better understand the molecular mechanism of EGF-stimulated programmed cell death, two stable cell lines of A43 (clone and clone 2) were established. Although the two cell lines have a similar level of receptor expression (Fig. 7C) , clone-2 cells displayed less mitochondrial EGFR especially at low confluence (Fig. 7A) . In contrast to clone-, EGF-related losses in clone-2 cell viability were less pronounced and likely caspasedependent (Fig. 7B) . When seeded at a high confluence (a relative nutrient-poor condition), clone-revealed a much higher upregulated expression of Beclin but a less increased mitochondrial EGFR in comparison to clone-2. This finding offers additional evidence of autophagic mediation of EGFR mitochondrial localization, and the upregulated Beclin expression is not totally in parallel with, or equivalent to, the increased level of mitochondrial EGFRs. Noticeably, clone-has a relatively larger amount of mitochondrial EGFR that is resistant to PK under a nutrient-poor condition (Fig.  7A) ; knocking down EGFR by siRNA led to a greater decrease of cell viability in this clone (p < 0.0) (Fig. 7C  and D ). All these findings suggest that the basal level of mitochondrial EGFR is involved in cell survival and correlated with the induced loss of cell viability.
Discussion
Using immunoelectron microscopy, we have confirmed the claim 5 that there is mitochondrial localization of EGFR. To our knowledge, this is the first verification of mitochondrial EGFR by IEM, which is considered the most convincing approach of examination of subcellular ultrastructure. 3 ,32 Also, we uncovered the fact that EGF could increase or decrease the amount of mitochondrial EGFR in a cell type-and timedependent manner. Meanwhile, EGF-induced loss of cell viability is correlated with the amount of basal mitochondrial EGFR and accompanied by a decrease in this subset of the receptor. In addition, by assessing the tolerance of the mitochondrially-associated EGFR to proteinase K and by examining the location of gold grains in IEM, we believe that EGFR can associate with both the inner and outer membrane of mitochondria depending on cell and mutant EGFR type. As demonstrated in Figure 7A , under high confluent conditions, more mitochondrial EGFRs in clone-can move to the compartment which is insensitive to PK digestion, whereas clone-2 displays a reduced PK-resistant receptor. The finding implies that PK-resistant mitochondrial EGFR may be alterable due to elements such as cell density, cell growth condition, nutritional status and some exogenous gene expression. Nevertheless, the exact mechanism of this alteration requires further exploration. Although the mitochondrial localization of EGFR was originally confirmed via examination of its interaction with an inner membrane protein, a possible presence on the outer membrane of the organelles for the receptor could not be totally excluded. Many proteins (e.g., Ras and Raf ) located on the outer membrane of the organelles 33, 34 have long been known to be the direct downstream molecules of the EGFR signaling pathway. 35 In addition, a protein (i.e., actin), which can directly bind with EGFR, was also found to associate with the outer membrane of mitochondria. [36] [37] [38] Therefore, we suspect EGFR may utilize a similar mechanism to migrate onto the outer membrane of the organelles as do the above mentioned proteins, although the mechanism of EGFR traveling onto the mitochondria needs to be explored further.
The mitochondria, a double-membrane organelle, plays a critical role during the process of energy generation. However, studies over the last decade have extended our prevailing view about mitochondrial function to far beyond merely supplying ATP. 39 It is now widely accepted that mitochondria are multifunctional organelles, which participate in a variety of cellular processes including programmed cell death execution and signal transduction. 39, 40 Proteins, such as protein kinases, protein phosphatases and even transcriptional factors, which are not traditionally mitochondrial resident members, now are revealed to have a mitochondrial location. 39, 4 Nevertheless, the molecular mechanism underlying these proteins (including EGFR) localization in mitochondria remains largely unknown. Our findings here provide clear evidence that autophagy can actively participate in the mediation of mitochondrial translocation of EGFR. Unexpectedly, depletion of Beclin was revealed to increase the basal localization of EGFR on mitochondria (Fig. 5) . When cells were cultured under high confluence, clone-showed a much higher upregulated Beclin but a less increased mitochondrial EGFR than clone-2 (Fig. 7A) . Together with the finding of Beclin knockdown, it suggests that the expression of Beclin is not totally in parallel with, or equivalent to, the increased or decreased level of mitochondrial EGFRs. On the contrary, rapamycin failed to increase EGFR mitochondrial migration in cells with a knockdown of Beclin , indicating that rapamycin stimulates mitochondrial transfer of EGFR via the Beclin -dependent process. These findings indicate that, in A43 cells, there may be present a redundant pathway in the regulation of mitochondrial localization of EGFR depending on cell conditions and type of treatment. Lopez-Ilasaca and co-workers reported that rapamycin treatment led to upregulated receptor autophosphorylation in A43 cells; yet, EGFR mitochondrial translocation was apparently unrelated to the receptors' tyrosine phosphorylation rate. 8 The mutant EGFR, which lacks four main tyrosine sites in the C terminus, appeared to have a mitochondrial location (Fig. 2C) . In fact, in PAE-C'022 cells, this mutant EGFR was still able to translocate onto mitochondria upon rapamycin stimulation (data not shown). Accordingly, these findings rule out any possibility that EGFR migrate into mitochondria via direct interaction with Shc adaptor proteins, which are located within mitochondria. 42, 43 The suppression of EGFR expression by siRNA or the inhibition of EGFR kinase activity by reagent (e.g., gefitinib), can be effective in the treatment of certain cancer cell types. [44] [45] [46] [47] However, the molecular mechanisms underpinning any anti-tumor activity of EGFR repression have not been fully elucidated. Our experiments indicate that cells with a greater extent of mitochondrial EGFR display a heightened sensitivity to the siRNA treatment and exhibit a greater lost of cell viability upon exposure to EGF. Therefore, it suggests that the extent of mitochondrial EGFR is regulatory in cell survival and In conclusion, our findings not only support the existence of mitochondrial EGFR, but also unravel a previously unknown mechanism of the receptor in the regulation of cell viability. Under certain unfavorable and harsh circumstances such as starvation and high confluence, EGFR was able to migrate onto mitochondria (or alter equilibrium across the membrane of the organelles) acting to sustain cell viability or to prevent programmed cell death from happening. Consequently, maintaining an adequate quantity of mitochondrial EGFR can be critical for cell survival in certain cell types. Additional experiments are needed to further explore the function of mitochondrial EGFR and to obtain a better understanding about how the mitochondria/EGFR relationship affects cellular biology.
Materials and Methods
Antibodies and chemicals. Antibodies of anti-mitochondrial heat shock protein 70 (MtHsp70), anti-early endosome antigen (EEA) and anti-EGFR were from Affinity Bioreagents (Golden, CO, USA); polyclonal antibodies: p70S6 kinase, Bcl-x L and Beclin were purchased from Cell Signaling Technology, Inc (Beverly, MA, USA); polyclonal rabbit antibody to EGFR, Ab293, was kindly provided by Dr. L Beguinot.
Rapamycin, 3-methyladenine, leupeptin, etoposide and polyclonal antibodies of β-actin and LC3 were purchased from Sigma-Aldrich. MitoTracker Red, and monoclonal antibodies to Cox IV were from Molecular Probes (Eugene, OR, USA). Mouse EGF was obtained from Collaborative Research Inc (Bedford, MA, USA). Pan-inhibitor of caspase, Z-VAD-FMK, was acquired from Calbiochem (San Diego, CA, USA).
Plasmid construction. The full-length of human Cox7a2 was cloned into pEYFP-N (Clontech, Palo Alto, CA). Site-directed mutagenesis of EGFR was carried out using QuikChange ® sitdirected mutagenesis kit according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, CA). GFP-LC3 was kindly provided by Dr. Tamotsu Yoshimori (Osaka University). In knockdown experiments, two pairs of EGFR siRNA (target sequences: 5' GGAAATATGTACTACGAAA 3', and 5' GTAACAAGCTCACGCAGTT 3') and siGENOME SMART pool BECN targeting Beclin was bought from Dharmacon (Denver, CO, USA). Control siRNA were purchased from Santa Cruz Biotechnology. Transfections were carried out as described before. 25 Subcellular fractionation. Cells were seeded into 50-mm dishes, with or without treatment (in full-serum medium). The cells were gathered, pelleted and washed three times with cold PBS. Cells were resuspended in homogenization buffer A (20 mM Hepes-KOH [pH 7.5], 250 mM sucrose, 0 mM KCl, .5 mM MgCl 2 , mM EGTA, mM EDTA, mM dithiothreitol, plus inhibitor) for 30-60 min, and subsequently homogenized at 6 x 0 6 cells/ml in 500 μl buffer A (the amount of cells from different treatments for fractionation are always adjusted to the same level), by 60 passages through a 25-G syringe needle on ice. The homogenate was centrifuged at 000 g for 5 min at 4°C; the resulting supernatant A was collected, and the pellet was washed twice with buffer A without sucrose, and saved as the nuclear fraction. Supernatant A was centrifuged (2,000 g for 5 min at 4°C); and the resulting supernatant B was saved and ultra-centrifuged (00,000 g for 40 min at 4°C). Following ultracentrifugation, the supernatant was collected as the cytosolic S00 (Cyt/S00) fraction and the pellet was labeled as the vescicular pellet. The pellet from supernatant A was washed two times with buffer A and labeled as the heavy membrane pellet (Hmmbp). The heavy mitochondrial pellet was overlaid on a two-step sucrose density gradient as described elsewhere, 26 and ultra-centrifuged at 60,000 g for 20 min at 4°C. The pellet was washed twice with buffer A (PMito). All the subcellular fractions were preserved at -80°C until further analysis.
Proteinase K treatment. The mitochondrial fractions were treated with 00 ng/mL proteinase K (PK) (Invitrogen) in buffer A without protease inhibitors at room temperature (RT) for 30 min. The reaction was stopped by the addition of mM phenylmethylsulfonylfluoride, and was analyzed by Western blotting using the indicated antibodies.
Cell culture and transfection. Cell lines of PAE stably expressing various mutated EGFR and green fluorescence protein (GFP)-tagged EGFR were described previously. 24, 25 New cell lines with kinase domain mutated receptors were established following the same standard single-cloning and G48 selection procedures. These cell lines were grown in F2/DMEM medium containing 0% fetal bovine serum, antibiotics and glutamine supplemented with G48. A43 cells were grown in DMEM containing 0% fetal bovine serum, antibiotics and glutamine. A43 cells were transfected with YFPCox7a2 or pEYFP-N vector respectively, and two stable cell lines were established following G48 selection. The Cox7a2-transfected cells were labeled as clone-, whereas vector-transfected cells were labeled as clone-2. Transient expressions were performed using Effectine (Qiagen; Valencia, CA).
Western blotting. The cells and pellets of subcellular fractionation were lysed in Triton X-00/glycerol solubilization buffer as described previously, 27 electrophoresed on SDS-PAGE and transferred to nitrocellulose membranes. Western blotting was carried out with several antibodies followed by detection using the enhanced chemiluminescence system (Pierce).
To determine the linear range of the chemiluminescence signals, X-ray films were quantitatively analyzed via densitometry.
Fluorescence microscopy. The fluorescence imaging workstation consisted of a Nikon inverted microscope equipped with a 00Xoil immersion objective lens, CCD SensiCam QE-6 MHz (Cooke, Germany), z-step motor, dual filter wheels and a Xenon 75-W light source and an 86004BS dichroic mirror (Chroma, Brattleboro, VT). The workstation was controlled by SlideBook 4.0 software (Intelligent Imaging Innovation, Denver, CO). For GFP-LC3 images, A43 cells were transfected with GFP-LC3, split onto coverslips after 24 hours transfection, and images were acquired through the GFP channel following the various treatments. For live cells images, glass coverslips with PAE cells stably expressing GFP-EGFR were prestained with MitoTracker Red and mounted in a microscopy chamber (Molecular Probes).
Immunofluorescence staining was carried out with the indicated antibodies as described previously. 27 Briefly, YFP-Cox7a2-transfected A43 cells and PAE cells stably expressing GFP-EGFR were permeabilized and immuno-stained with the indicated antibody, respectively, followed by Cy3-labeled secondary antibodies that allowed imaging. All images were finally arranged using Adobe Photoshop (Adobe System, Mountain View, CA).
Cell proliferation assay. After transfecttion with siRNA to EGFR for 48 hours (portions of the cells for western blot), cells were split and seeded in 96-well plates and cultured for another 24 hours before the assay. Cells were plated in 96-well plates (4000 cells per well) in 00 μL complete culture medium. After overnight culture, the medium was replaced with either drug-free, EGF or chemicals in complete medium. The cells were cultured at the times indicated, and cellular viability was determined with cell Titer 96 Aqueous Nonradioactive Cell Proliferation Assay kit (Promega, Madison, WI).
Immunoelectron microscopy (IEM). Samples of human epidermoid carcinoma A43 cells were fixed with 2% paraformaldehyde overnight at 4°C. The next day, samples were washed with sucrose buffer twice for 30 minutes each and blocked in 0.5 M ammonium chloride for one hour at 4°C. Subsequent dehydration of samples was performed in a graded series of ethanol (30%-00%). The samples were embedded in Lowicryl K4M resin (Ladd Research Industries; Burlington, VT) at -35°C and were polymerized under UV light at room temperature for 2-3 days. Ultrathin sections were then cut and collected on pioloformcoated nickel grids to continue the immunolabeling experiments.
The sections were pre-incubated in x PBS (pH 7.4) containing 2% bovine serum albumen (BSA) for 0 minutes and then incubated with rabbit polyclonal antibody directed against EGFR. The primary antibody was bought from ABR, diluted as :50 according to the manufacturer's instructions in x PBS (pH 7.4) containing % BSA and was incubated at 4°C in a moist chamber overnight. The sections were then washed in a drop of x PBS (pH 7.4) six times for 3 minutes each, x PBS (pH 8.2) twice for 3 minutes each and blocked in x PBS (pH 8.2) containing 2% BSA for 0 minutes. Then sections were placed on a drop of goat anti-rabbit secondary antibody conjugated to 0-nm colloidal gold particles (diluted :40 in x PBS, pH 8.2) at room temperature for 2 hours. After incubation with the secondary antibody, the sections were washed five times in x PBS (pH 8.2), five times in x PBS (pH 7.4) and five times in distilled water for 3 minutes each. The dried sections were then stained with sodium acetate and were observed under a transmission electron microscope. and harvested, washed with PBS and incubated with a fluorescein isothiocyanate-labeled annexin V (Cy5) and stained with propidium iodide (PI) (Molecular Probes). Percentages of cells that were Annexin V-positive/PI-negative were determined by flow cytometry. Morphological analysis of apoptosis. For morphological analysis of apoptosis, cell morphology was evaluated by fluorescence microscopy after staining with 4'-6-diamidino-2-phenylindole (DAPI). After 24 hours incubation with etoposide or depletion of serum, cellular DNA was stained with μg/ml of DAPI dissolved in PBS for 30 minutes. The slides were then viewed on a fluorescence microscope. DAPI permeates the plasma membrane and yields blue chromatin. Viable cells display normal nuclear size and blue fluorescence, whereas apoptotic cells show condensed chromatin and fragmented nuclei.
Statistical analysis. The data of normal distribution were shown as mean ± SD and analyzed by one-way ANOVA. When significance existed, differences between groups were determined further by Student-Newman-Keuls.
